CCL24產(chǎn)品信息
英文名稱:Chemokine (C-C Motif) Ligand 24
中文名稱:趨化因子CCL24
靶點別稱:CCL24
物種:Human
標(biāo)簽:His Tag
屬性:Protein
標(biāo)記:Unconjugated
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human CCL24, His Tag (CC4-H52H1) is expressed from human 293 cells (HEK293). It contains AA Val 27 - Cys 119 (Accession # O00175).
Predicted N-terminus: Val 27
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 12.3 kDa. The protein migrates as 18-21 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-HPLC.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
C-C基序趨化因子配體24(CCL24),也稱為eotaxin2,屬于類似MCP-1的CC趨化因子,主要趨化嗜酸性粒細(xì)胞。CCL24可以促進(jìn)嗜酸性粒細(xì)胞與內(nèi)皮細(xì)胞的分離,然后與其唯一的配體結(jié)合,促進(jìn)嗜酸性細(xì)胞進(jìn)入組織。CCL24最初在嗜酸性粒細(xì)胞中沒有發(fā)現(xiàn),但最初是從單核細(xì)胞中分離出來的。最近,發(fā)現(xiàn)哮喘患者支氣管上皮細(xì)胞中CCL24的表達(dá)增加。CCL24通過CCR3受體(C-C趨化因子受體3型)促進(jìn)免疫細(xì)胞運輸和活化以及促纖維化活性。CCL24和CCR3都參與肺部和皮膚炎癥和纖維化。
關(guān)鍵字: CCL24;CCL24蛋白;CCL24重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。